Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

514.56
-6.5600-1.26%
Post-market: 515.601.04+0.20%18:33 EDT
Volume:815.05K
Turnover:420.69M
Market Cap:130.55B
PE:29.95
High:522.60
Open:519.13
Low:514.32
Close:521.12
52wk High:560.25
52wk Low:374.17
Shares:253.72M
Float Shares:253.72M
Volume Ratio:0.75
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.45
PE(LYR):33.59

Loading ...

Vertex Pharmaceuticals BDR Program Executes 8-for-1 Stock Split in Brazil on July 27

Reuters
·
Jul 16

Vertex Pharmaceuticals Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since August 2021

Dow Jones
·
Jul 15

After Crinetics’ $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story?

TIPRANKS
·
Jul 15

Crinetics Pharmaceuticals (CRNX) Looks Fully Valued As Vertex Agrees $85 Per Share Deal

Simply Wall St.
·
Jul 15

Vertex Minerals lifts gold sales and advances mechanised mining at Reward

TIPRANKS
·
Jul 14

Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 14

Vertex Pharmaceuticals is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 14

UBS Adjusts Vertex Pharmaceuticals Price Target to $585 From $545, Maintains Buy Rating

MT Newswires Live
·
Jul 13

BMO Capital Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jul 13

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 11

Crinetics Pharmaceuticals Announces Merger Agreement With Vertex

TIPRANKS
·
Jul 11

Vertex: Buy Rating Reaffirmed as Crinetics Deal Broadens Revenue Base; $575 Price Target Maintained

TIPRANKS
·
Jul 10

RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $577 From $570

MT Newswires Live
·
Jul 10

Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09

Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.09% on Jul 8: Key Drivers Unveiled

TradingKey
·
Jul 09

Movement Alert|Vertex Pharmaceuticals Falls 3.24% in Regular Trading, $10 Billion Crinetics Acquisition Triggers Market Digestion Pressure

Market Focus
·
Jul 09

Analysts Conflicted on These Healthcare Names: Certara (CERT), Nurix Therapeutics (NRIX) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jul 08

Jefferies Adjusts Vertex Pharmaceuticals Price Target to $610 From $580

MT Newswires Live
·
Jul 08

Morgan Stanley's Analysis of Vertex's Major Acquisition of Crinetics: Enhancing Endocrine Portfolio and Unlocking Growth Potential

Stock News
·
Jul 08

Crinetics downgraded to In Line from Outperform at Evercore ISI

TIPRANKS
·
Jul 08